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Abstract
 
Linker for activation of B cells (LAB, also called NTAL; a product of 
 
wbscr5
 
 gene) is a newly
identified transmembrane adaptor protein that is expressed in B cells, NK cells, and mast cells.
Upon BCR activation, LAB is phosphorylated and interacts with Grb2. LAB is capable of rescuing
thymocyte development in LAT-deficient mice. To study the in vivo function of LAB, LAB-
deficient mice were generated. Although disruption of the 
 
Lab
 
 gene did not affect lymphocyte
development, it caused mast cells to be hyperresponsive to stimulation via the Fc
 
 
 
RI, evidenced
by enhanced Erk activation, calcium mobilization, degranulation, and cytokine production.
These data suggested that LAB negatively regulates mast cell function. However, mast cells that
lacked both linker for activation of T cells (LAT) and LAB proteins had a more severe block in
Fc
 
 
 
RI-mediated signaling than LAT
 
 
 
/
 
 
 
 mast cells, demonstrating that LAB also shares a redun-
dant function with LAT to play a positive role in Fc
 
 
 
RI-mediated signaling.
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Introduction
 
Engagement of the high affinity IgE receptor (Fc
 
 
 
RI) at
the surface of mast cells initiates signaling cascades leading
to Ras–mitogen-activated protein kinase (MAPK) activation,
calcium mobilization, degranulation, and cytokine production
(1–4). Fc
 
 
 
RI, a member of the immunoreceptor superfamily,
is composed of 
 
 
 
, 
 
 
 
, and the homodimeric 
 
 
 
 chains (5).
The 
 
 
 
 chain binds IgE, and the 
 
 
 
 and 
 
 
 
 chains contain a
signal-transducing immunoreceptor tyrosine-based activation
motif (ITAM) in their cytoplasmic domains. Upon activa-
tion of Fc
 
 
 
RI by multivalent antigens bound on IgE, the
Src family tyrosine kinase (protein tyrosin kinase [PTK]),
Lyn, is activated and phosphorylates the tyrosine residues
within the ITAMs of the 
 
 
 
 and 
 
 
 
 chains. Syk then binds to
the phosphorylated ITAMs via its tandem Src homology 2
domains and is further activated by Lyn (6, 7). These acti-
vated tyrosine kinases further phosphorylate downstream
signaling molecules. The importance of these tyrosine kinases
in mast cell function has been demonstrated in cells defi-
cient in these PTKs. Syk-deficient mast cells fail to degran-
ulate and secrete cytokines when stimulated through the
Fc
 
 
 
RI (8). Compared with Syk deficiency, Lyn deficiency
has a less severe phenotype. Lyn
 
 
 
/
 
 
 
 mast cells have impaired
tyrosine phosphorylation of proteins and delayed Ca
 
2
 
 
 
 mobili-
zation, but degranulation, MAPK activation, and cytokine
production occur normally (9). This partial signaling defect
caused by Lyn deficiency is likely due to the presence of
another Src family PTK, Fyn (10). Although Fyn
 
 
 
/
 
 
 
 mast
cells are relatively normal in Fc
 
 
 
RI-mediated tyrosine phos-
phorylation, MAPK activation, and Ca
 
2
 
 
 
 flux, they are de-
fective in IgE-dependent degranulation (11). Fyn functions
to phosphorylate Gab2, an adaptor molecule that is impor-
tant in Fc
 
 
 
RI-mediated phosphotidylinositide 3-kinase ac-
tivation (11, 12). Therefore, both Lyn and Fyn are required
in Fc
 
 
 
RI-mediated signaling pathway.
After activation of these PTKs, many signaling proteins
are phosphorylated. One of the prominently phosphory-
lated proteins downstream of Fc
 
 
 
RI engagement is linker
for activation of T cells (LAT). LAT function has been
clearly demonstrated in T cells. Upon T cell activation, it is
phosphorylated and interacts with Grb2, Gads, and PLC-
 
 
 
1
(13–15). Through binding to these molecules, LAT couples
TCR engagement to MAPK activation and calcium flux.
In LAT-deficient Jurkat cells, TCR-mediated MAPK acti-
vation and calcium flux are completely blocked (16, 17).
LAT is also required during T cell development. LAT-
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deficient mice lack mature T cells, and thymocyte develop-
ment is blocked at the double negative stage (18). In
LAT
 
 
 
/
 
 
 
 mast cells, although tyrosine phosphorylation of
Fc
 
 
 
RI, Syk, and Vav is intact, Fc
 
 
 
RI-mediated phosphor-
ylation of SLP-76, PLC-
 
 
 
1, and PLC-
 
 
 
2, MAPK activa-
tion, and calcium mobilization are significantly reduced,
leading to a reduction in mast cell degranulation and cyto-
kine production (19). Mutational studies show that four
membrane-distal tyrosines in LAT are required for LAT
function in Fc
 
 
 
RI-mediated signaling (20). In comparison
with the LAT-deficient Jurkat cells, Fc
 
 
 
RI-mediated sig-
naling and effector function in LAT
 
 
 
/
 
 
 
 mast cells are not
completely blocked. LAT
 
 
 
/
 
 
 
 mast cells still flux calcium
and produce cytokines after engagement of Fc
 
 
 
RI, albeit at
reduced levels. These data suggest that Fc
 
 
 
RI-mediated
signaling is not totally dependent on LAT.
Recently, a novel transmembrane adaptor protein, linker
for activation of B cells (LAB)/non–T cell activation linker
(NTAL), was identified (21, 22). Similar to LAT, LAB has
multiple tyrosine residues in its cytoplasmic tail, five of
which are within a Grb2-binding motif. LAB also has a
palmitoylation motif and is localized to lipid rafts. LAB is
expressed in B cells, NK cells, mast cells, and other cell
types. Upon BCR or Fc receptor engagement, LAB is
phosphorylated and interacts with Grb2; however, it is in-
capable of binding PLC-
 
 
 
1 or PLC-
 
 
 
2 (21–23). Function-
ally, LAB is able to rescue thymocyte development in
LAT
 
 
 
/
 
 
 
 mice. However, transgenic mice expressing LAB
in T cells develop a Th
 
2
 
 autoimmune disease similarly to
the LAT Y136F knockin mice, suggesting that LAB resem-
bles the LAT mutant without the PLC-
 
 
 
1 site (24). These
data suggest that, although LAT and LAB share a subset of
functions in signaling, they function differently.
To study how LAB functions in vivo, we generated
LAB-deficient mice. Although disruption of the 
 
Lab
 
 gene
had no significant impact on T and B cell development, it
caused mast cell hyperresponsiveness to stimulation via
Fc
 
 
 
RI, suggesting that LAB negatively regulates mast cell
function. Interestingly, mast cells deficient in both 
 
Lat
 
 and
 
Lab
 
 genes had further reduction in Fc
 
 
 
RI-mediated signal-
ing and mast cell function in comparison with LAT
 
 
 
/
 
 
 
mast cells. Thus, LAB also plays a positive role in Fc
 
 
 
RI-
mediated signaling.
 
Material and Methods
 
Generation of LAB
 
 
 
/
 
 
 
 Mice by Gene Targeting. Lab
 
 genomic
fragments were amplified from ES cells by PCR and cloned into
the XpPNT targeting plasmid. Seven exons, which encode the
LAB protein from residues 1 to 113, were deleted. After linearized
with NotI, this targeting construct was used to transfect embryonic
stem (ES) cells. ES transfectants were selected in the presence of
G418 and gancyclovir. Out of 250 G418–resistant ES clones, seven
positive clones underwent homologous recombination by PCR
screening and Southern blot analysis. Four of these targeted ES
clones were injected into blastocysts from C57Bl/6 mice to gener-
ate chimeric mice. These mice were then used to cross with
C57Bl/6 mice to produce LAB
 
 
 
/
 
 
 
 mice. LAB
 
 
 
/
 
 
 
 mice were ob-
tained by interbreeding LAB
 
 
 
/
 
 
 
 mice. Southern blot analysis of the
genomic DNA from ES cells and mouse littermates was performed
using ExpressHyb hybridization solution (CLONTECH Laborato-
ries, Inc.). PCR genotyping of littermates was performed using
three primers (5
 
 
 
-GGAAGTAACCAGGAGCCTGATGCTGC-
3
 
 
 
, 5
 
 
 
-CGGGCTAGAGATGTCAGGCTTTATGG-3
 
 
 
, and 5
 
 
 
-
TCGCAGCGCATCGCCTTCTATCG-3
 
 
 
). 2KO mice (LAB
 
 
 
/
 
 
 
LAT
 
 
 
/
 
 
 
) were obtained by breeding LAB
 
 
 
/
 
 
 
 and LAT
 
 
 
/
 
 
 
 fol-
lowed by interbreeding LAB
 
 
 
/
 
 
 
LAT
 
 
 
/
 
 
 
. Fyn
 
 
 
/
 
 
 
 and Lyn
 
 
 
/
 
 
 
mice were purchased from the Jackson Laboratories. All mice were
used in accordance with National Institutes of Health guidelines.
 
Antibodies and Flow Cytometry Analysis.
 
Antibodies used for
immunoprecipitation were anti-LAT (13), LAB (22), Grb2, SLP-
76, and PLC-
 
 
 
2 (Santa Cruz Biotechnology), and PLC-
 
 
 
1 (Up-
state Biotechnology). Antibodies used for immunoblotting were
anti-pTyr (4G10; Upstate Biotechnology, Inc.), SLP76 (Trans-
duction laboratory), and Lyn (Santa Crutz Biotechnology, Inc.).
Monoclonal anti-LAT (11B12) was generated by fusion of NSO
cells with splenocytes from mice immunized with glutathione
 
S
 
-transferase–LAT (human) fusion protein. Antibodies for the
MAPK assay were anti-phospho–Erk, –Jnk, and –p38 MAPK
from Cell Signaling.
Antibodies used in FACS analysis of lymphocyte development
were the following: APC-conjugated anti-CD8 and B220, FITC-
conjugated anti-CD4 (eBioscience), FITC-conjugated anti-IgM
and IgD, PE-conjugated anti-IgM and CD43 (BD Biosciences).
For IgE receptor expression level, cells were stained with biotin-
conjugated anti-Fc
 
 
 
RI
 
 
 
 (eBioscience) followed by streptavidin-
conjugated FITC. Flow cytometry was performed using the Bec-
ton Dickinson FACSCalibur and analyzed by the CELLQuest
software.
 
BM-derived Mast Cells Culture, Activation, Immunoprecipitation,
and Western Blot.
 
BM cells were taken from WT, LAB
 
 
 
/
 
 
 
,
LAT
 
 
 
/
 
 
 
, and 2KO mouse femurs and were cultured in mast cell
medium (Iscove’s modified Dulbecoo’s medium supplemented
with 10% FBS, 
 
 
 
-mercaptoethanol, penicillin, and streptomycin)
in the presence of recombinant IL-3 (5 ng/ml) at 37
 
 
 
C for 3–6
wk before analysis.
BM-dervied mast cells (BMMCs) (2–5 
 
 
 
 10
 
6
 
/ml) were pre-
loaded with anti-DNP IgE (0.5 
 
 
 
g/ml, SPE-7 mAb; Sigma-
Aldrich) in IMDM medium without IL-3 for 4 h. Cells were
washed with IMDM and then stimulated with DNP-HSA (20
ng/ml) for the indicated time points. A total of 1
 
 
 
10
 
7
 
 cells were
lysed in 500 
 
 
 
l of ice cold Brij lysis buffer (1% Brij-97, 25 mM
Tris-Cl, pH 7.6, 150 mM NaCl, 5 mM EDTA, 1 mM Na
 
3
 
VO
 
4
 
)
or RIPA lysis buffer (1% Triton, 0.5% sodium deoxycholic acid,
0.1% SDS, 25 mM Tris-Cl, pH 7.6, 150 mM NaCl, 5 mM
EDTA, 1 mM Na
 
3
 
VO
 
4
 
). Lysates were subjected to immunopre-
cipitation with protein A beads bound with various antibodies.
Lipid raft and nonraft fractions were purified as described previ-
ously (25).
For Western blotting, samples were separated by SDS-PAGE
and transferred to nitrocellulose membranes. After incubation
with primary antibodies, nitrocellulose membranes were washed
three times and probed with either anti–mouse or rabbit Ig con-
jugated to AlexaFluor 680 (Molecular Probes) or IRDye800
(Rockland). Membranes were then visualized with the LI-COR
Bioscience Odyssey system (LI-COR).
 
Passive Systemic Anaphylaxis.
 
Mice were sensitized with 2 
 
 
 
g
of anti–DNP-IgE by i.v. injection for 20–24 h. They were then
injected i.v. with 200 
 
 
 
g of DNP-HSA for 1.5 min. Mice were
killed with CO
 
2
 
, and blood was immediately collected by cardiac
puncture. Histamine concentration in serum was determined us-
ing a competitive histamine ELISA assay kit (Immunotech). 
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Ca
 
2
 
 
 
 Flux.
 
BMMCs (2–5 
 
 
 
 10
 
6
 
/ml) were preloaded with
anti-DNP IgE (0.5  g/ml) in IMDM without IL-3 for 4 h. Cells
were washed twice with IMDM and then loaded with 5  M Fluo-
4 AM (Molecular Probes) for 30 min. Cells were washed again and
further incubated in IMDM for 30 min. DNP-HSA (30 ng/ml)
and thapsigargin (1  M) were used to induce calcium flux in these
cells. Ca2  flux was measured using a flow cytometer (FACSCali-
bur; BD Biosciences) to monitor the fluorescence emission.
Degranulation Assay. Degranulation of BMMCs was deter-
mined by measuring the release of  -hexosaminidase. Briefly,
BMMCs (2–5   106/ml) were preloaded with anti-DNP IgE (0.5
 g/ml) in medium without IL-3 for 4 h. Cells were then washed
with IMDM. Sensitized cells (2   106 cells/ml) were stimulated
with different concentrations of DNP-HSA (1, 10, 100, 1,000 ng/
ml) and 1  M thapsigargin for 10 min in Tyrode’s buffer. The re-
actions were stopped by putting the tubes on ice followed by cen-
trifugation. Supernatants were collected, and cell pellets were
solubilized with 0.5% Triton X-100 in Tyrode’s buffer. The en-
zymatic activity of  -hexosaminidase was measured with p-nitro-
phenyl N-acetyl- -glucosaminide in 0.1 M sodium citrate (pH
4.5) for 60 min at 37 C. The reaction was stopped by addition of
0.2 M glycine (pH 10.7). The release of the product 4-p-nitro-
phenol was detected by measuring absorbance at 405 nm. The ex-
tent of degranulation was calculated by dividing the absorbance in
the supernatant by the sum of absorbance in the supernatants and
in the cell pellets solubilized in 0.5% Triton X-100.
Detection of Cytokine Production. BMMCs were sensitized in
0.5  g/ml for 4–16 h followed by stimulation with 20 ng/ml of
DNP-HSA for 1 h. Total RNAs were isolated with the Trizol
reagent (Invitrogen). First strand cDNAs were synthesized using
the Superscript RT-PCR kit (Invitrogen). cDNAs were then
used as templates for amplification of various cytokines. The
primer pairs for amplification of different cytokines were the fol-
lowing: IL-3, 5 -GTGGCCGGGATACCCACCGTTTAAC-
3 , 5 -TGGCAGGGCAGAGTCATTCGCAGA-3 ; IL-4, 5 -
GTCTCTCGTCACTGACGGCACAGAG-3 , 5 -GCATGG-
TGGCTCAGTACTACGAGTA-3 ; IL-6, 5 -CGCTATGAA-
GTTCCTCTCTGCAAG-3 , 5 -GTAGCATCCATCATTTC-
TTTGTATC-3 ; TNF , 5 GCGACGTGGAACTGGCAG-
AAGAGG-3 , 5 -GTACTTGGGCAGATTGACCTCAGC-3 ;
IFN , 5 -CTTCTTCAGCAACAGCAAGGCGAAA-3 , 5 -
CCCCAGATACAACCCCGGAATCA-3 ; actin, 5 -ACTCC-
TATGTGGGTGACGAG-3 , 5 -CAGGTCCAGACGCAGG-
ATGGC-3 . The concentration of cytokines secreted by mast
cells into the tissue culture supernatant was determined by mouse
18-Plex cytokine assay according to the manufacturer’s protocol
(Bio-Rad Laboratories, Inc.).
Results
Generation of LAB-deficient Mice. To determine LAB
function in vivo, we generated LAB-deficient mice by
gene targeting. A 1.6-kb genomic fragment was cloned as
the short arm, and a 6-kb genomic fragment was used as
the long arm in the targeting construct to delete exons 2
through 8 (Fig. 1 A). These exons encode the NH2-termi-
nal part of LAB protein from residues 1–113, which in-
cludes the transmembrane domain and palmitoylation site.
This construct was used to transfect ES cells. Out of 250
transfected ES clones, seven clones underwent homologous
recombination. Targeted ES cells were injected into blasto-
cysts to produce chimeric mice. Crossing the chimeras with
C57Bl/6 mice produced heterozygous mice (LAB / ).
These heterozygous mice (LAB / ) were inbred to obtain
homozygous mice for the disrupted Lab gene (LAB / ).
Southern analysis using a probe in Fig. 1 A showed that
the Lab gene was successfully targeted and the mutant allele
was transmitted from the chimeric mice to their offspring.
The sizes of DNA fragments of the targeted and WT alleles
Figure 1. Disruption of the Lab
gene in mice. (A) The targeting
construct was made to replace
seven exons with the Neo cassette.
(B) The genomic DNA from four
littermates from LAB /  inter-
breeding was digested with XbaI
and analyzed by Southern blot us-
ing a probe as shown in A. The
sizes of the DNA fragment de-
tected by this probe were expected
to be 10.8 kb for the WT allele
and 4.6 kb for the targeted allele
(KO). (C) PCR products were
amplified from the genomic DNA
of four littermates using three
primers indicated by arrows in A.
The size of the PCR products was
expected to be 500 bp for WT
allele and 600 bp for targeted allele
(KO). (D) Absence of LAB pro-
tein in LAB /  mice. Postnuclear
lysates of splenocytes and BM-
derived mast cells from WT and
LAB /  mice were immunopre-
cipitated with rabbit anti-LAB. Immunoprecipitates were then analyzed by Western blotting with monoclonal anti-LAB. (E). Normal T and B cell development
in LAB /  mice. Cells from thymus, spleen, and BM were stained with antibodies as indicated in each panel. Flow cytometry was performed and analyzed by
the CELLQuest software.LAB/NTAL in Mast Cell Signaling 994
were the same as predicted (Fig. 1 B). Littermates were also
genotyped by PCR using three primers (Fig. 1 C). Success-
ful deletion of the Lab gene was further confirmed by im-
munoprecipitation of LAB from splenocyte and mast cell
lysates followed by an anti-LAB blot. LAB protein was
clearly absent in cells from LAB /  mice (Fig. 1 D). LAB / 
mice were born at the expected Mendelian frequency and
remained viable and apparently healthy in a pathogen-free
environment. WT and LAB /  mice were indistinguishable
in terms of their appearance and size. To study whether
LAT and LAB have any redundant roles in lymphocyte
development and signaling, mice deficient in both LAT
and LAB genes were generated by crossing LAB /  with
LAT /  to produce LAT / LAB /  mice. LAT / LAB / 
mice were inbred to produce double deficient mice
(LAB / LAT / , simplified as 2KO mice throughout the
text).
Normal T and B Cell Development in LAB /  Mice. The
sizes of thymus, spleen, and LNs from LAB /  mice were
similar to those from WT mice. Analysis of cells from BM,
thymus, spleen, and LN by FACS revealed normal devel-
opment of T and B lymphocytes. The percentages of
CD4 CD8 , CD4 , and CD8  cells in the thymus of
LAB /  mice were similar to those in WT mice (Fig. 1 E).
The percentages of CD4  and CD8  T cells were also nor-
mal in spleen and LN of LAB /  mice (not depicted). This
result was expected since LAB is not expressed in resting T
cells. However, even though LAB is expressed in B cells
disruption of the Lab gene had no effect on B cell develop-
ment as the percentages of pro–B cells (IgM B220 
CD43 ), pre–B cells (IgM- B220 CD43-), and immature
(B220loIgM ) and mature (B220hiIgM ) B cells in BM
were similar to those in WT mice (Fig. 1 E and not de-
picted). No difference was observed in the percentages of
splenic B cells expressing IgM, IgD, or both (Fig. 1 E).
Dendritic and NK cell development was not affected in
LAB /  mice (not depicted). LAB function in B cells and
immune responses is currently under investigation.
LAB Is Phosphorylated and Interacts with Grb2 upon Fc RI
Ligation. Lyn and Fyn tyrosine kinases play important roles
in mast cell function. Upon Fc RI engagement, these ki-
nases are activated and subsequently phosphorylate down-
stream signaling proteins. Similar to LAT, LAB is also ex-
pressed in mast cells and is phosphorylated upon activation of
mast cells via Fc RI (21, 23). In fact, LAB protein was more
abundant in mast cells than in splenocytes (Fig. 1 D). We
first examined whether disruption of the Lyn or Fyn gene af-
fects phosphorylation of LAB and LAT in mast cells. Long-
term mast cell lines (BMMCs) were derived from BM cells
of WT, Lyn / , and Fyn /  mice. These cells were cultured
in the medium with IL-3 for 3–6 wk and were used in sub-
sequent experiments. After being sensitized with monoclonal
anti-DNP IgE, mast cells were activated by cross-linking
with DNP-HSA for 2 min before lysis. Postnuclear lysates
were then subjected to immunoprecipitation with anti-LAB
or LAT sera. Lysates and immunoprecipitates were resolved
on SDS-PAGE and analyzed by Western blotting with anti-
pTyr (phosphotyrosine), LAB, and LAT, respectively. As re-
ported previously (9, 11), Fc RI-mediated tyrosine phos-
phorylation of signaling proteins was dramatically reduced in
Lyn /  mast cells, whereas it was relatively normal in Fyn / 
cells (Fig. 2 A). Immunoprecipitation of LAT showed that
LAT phosphorylation was significantly reduced in Lyn / 
cells compared with it in WT and Fyn /  cells; however, it
was still phosphorylated. Fyn deficiency had no effect on
LAT phosphorylation. LAB was phosphorylated upon acti-
vation of WT mast cells (Fig. 2 A). Phosphorylated LAB ap-
peared as a doublet on SDS-PAGE. Phosphorylation of LAB
was almost completely abolished in Lyn / cells. In Fyn / 
cells, phosphorylation of LAB was slightly reduced compared
with WT cells. These results indicated that Lyn, not Fyn, is
required for tyrosine phosphorylation of the transmembrane
adaptor proteins LAT and LAB.
Increased Tyrosine Phosphorylation of LAB in LAT /  Mast
Cells. Previous studies showed that LAT is important in
Fc RI-mediated MAPK activation, Ca2  flux, and degranu-
Figure 2. Fc RI-mediated LAB tyrosine
phosphorylation and association with Grb2.
BMMCs were sensitized with anti-DNP
IgE and stimulated with DNP-HSA for 1.5
min or the indicated time. Postnuclear lysates
were immunoprecipitated and blotted with
indicated antibodies. (A) Phosphorylation
of LAB and LAT in BMMCs from WT,
Lyn / , and Fyn /  mice. (B). Phosphory-
lation of LAB in BMMCs from WT and
LAT /  mice. (C) LAB association with
Grb2 in WT and LAT /  BMMCs.Zhu et al. 995
lation; however, disruption of the Lat gene in mast cells fails
to completely abolish Fc RI-mediated signaling as LAT / 
mast cells still flux calcium and produce some cytokines
upon activation (19). Because LAB and LAT contain similar
tyrosine motifs and both are localized to lipid rafts, we spec-
ulated that LAB might compensate for the loss of LAT in
LAT /  mast cells. We examined whether phosphorylation
of LAB is affected in LAT /  mast cells. Fc RI-mediated ty-
rosine phosphorylation of proteins was examined similarly as
in Fig. 2 A. As shown in Fig. 2 B, although overall tyrosine
phosphorylation of proteins in LAT /  mast cells was similar
to that in WT cells, there was an increase in phosphorylation
of proteins with the molecular weight of  30 kD. Since
LAB migrates on SDS-PAGE as a 30–32-kD protein, it is
possible that this protein is LAB. Immunoprecipitation with
anti-LAB sera revealed that LAB phosphorylation was in-
deed increased in LAT /  mast cells (Fig. 2 B). Although it
appeared that there was less LAB protein precipitated from
activated mast cells at 0.75 and 1.5 min as shown in an anti-
LAB blot, this was likely because our antibody did not
recognize phosphorylated LAB well. We also determined
whether LAB associates with Grb2 upon Fc RI engage-
ment. LAB and Grb2 were immunoprecipitated from lysates
of resting and stimulated mast cells, followed by Western
blotting with anti-pTyr and anti-Grb2. As shown in Fig. 2
C, Grb2 immunoprecipitated both phosphorylated LAT and
LAB in WT, and LAB only in LAT /  mast cells. Grb2 was
also detected in anti-LAB immunoprecipitates from both
mast cell lines. These data indicated that LAB is phosphory-
lated and interacts with Grb2 upon engagement of Fc RI. In
the absence of LAT, LAB phosphorylation was increased.
IgE-dependent Anaphylaxis in LAB /  Mice. Since LAB
was phosphorylated and interacted with Grb2 upon Fc RI
engagement, we next examined whether disruption of LAB
affects mast cell function in vivo. Passive systemic IgE-
dependent anaphylaxis in WT and LAB-deficient mice was
performed. This assay is dependent on in vivo mast cell
degranulation and histamine release after engagement of
Fc RI. Mice were first injected via a tail vein with mono-
clonal anti-DNP IgE. At 20–24 h after injection, mice were
challenged with DNP-HSA. At 1.5 min after challenge,
mice were killed and blood was collected for measuring his-
tamine concentration using competitive ELISA. As shown
in Fig. 3 A, LAB /  mice were capable of releasing hista-
mine upon challenging with DNP-HSA similar to WT
mice, if not slightly higher. These data indicate that LAB de-
ficiency did not lead to a block in mast cell function in vivo.
Enhanced Fc RI Signaling in LAB /  Mast Cells. LAB
function in mast cells was further analyzed using mast cells
derived from BM cells of WT and LAB /  mice. We also
derived mast cells from LAT /  and 2KO mice to compare
Fc RI-mediated signaling in these cells with it in WT and
LAB / cells. Mast cells developed normally from BM cells
of WT, LAB / , LAT / , and 2KO mice in the presence
of IL-3. These mast cell lines expressed similar levels of IgE
receptor (Fig. 3 B) and c-kit (not depicted). We first deter-
mined whether the effector function of LAB /  mast cells
is normal by examining antigen-induced degranulation.
Mast cells were sensitized with anti–DNP-IgE and cross-
linked with different amounts of DNP-HSA. Release of
 -hexosaminidase from granules was then assayed. As indi-
cated in Fig. 3 C, antigen-induced degranulation peaked at
a concentration of 10 ng/ml for mast cells from WT and
LAB /  mice; however, compared with the granule release
in WT cells, Fc RI-mediated granule release was signifi-
cantly enhanced in LAB /  cells. Similar to LAT /  mast
cells, 2KO mast cells failed to degranulate upon stimulation
with DNP-HSA. These cell lines released similar amounts
Figure 3. The effect of LAB deficiency on
IgE-mediated systemic anaphylaxis and degran-
ulation. (A) IgE-mediated systemic anaphylaxis.
Mice (n   10) were sensitized with anti-DNP
IgE and challenged with DNP-HSA. Histamine
concentration in blood was measured by
ELISA. (B) Surface IgE receptor expression on
BMMCs from WT, LAT / , LAB / , and
2KO mice. BMMCs were stained with biotin–
anti-Fc RI  (filled curves) or biotin-IgG1 as an
isotype control (opened curves) followed by
streptavidin-FITC. (C and D) Degranulation
was determined by measuring the release of
granular  -hexosaminidase after stimulation with
DNP-HSA (C) or thapsigargin (D).LAB/NTAL in Mast Cell Signaling 996
of  -hexosaminidase in response to stimulation by thapsi-
gargin, which bypasses receptor engagement (Fig. 3 D).
Next, we examined Fc RI-mediated signaling in WT,
LAT / , LAB / , and 2KO cells. Mast cells were sensitized
with anti-DNP IgE followed by cross-linking with DNP-
HSA for 0, 1.5, and 5 min before lysis. Lysates were ana-
lyzed by anti-pTyr blotting. As shown in Fig. 4 A, overall
tyrosine phosphorylation of proteins, with exception of
LAT and LAB, was similar in mast cells derived from WT,
LAB / , LAT / , and 2KO mice. However, there was in-
creased phosphorylation of proteins over 90 kD in LAB / 
cells. Immunoprecipitation of PLC- 1 and PLC- 2 showed
that phosphorylation of these two proteins was increased in
LAB /  mast cells compared with that in WT, LAT / ,
and 2KO cells. Phosphorylation of SLP-76 was similar in
WT and LAB /  cell lines (Fig. 4 B).
LAT plays an essential role in TCR-mediated calcium
mobilization by recruiting PLC- 1 to the membrane for ac-
tivation. In mast cells, LAT deficiency only leads to a modest
reduction in Fc RI-mediated calcium flux (19). To exam-
ine activation-induced intracellular calcium elevation, mast
cells were sensitized with anti-DNP IgE, loaded with cal-
cium-sensitive dye Fluo-4, and activated with DNP-HSA.
LAT /  mast cells showed a reduction in calcium flux com-
pared with WT cells (Fig. 5 A). In contrast, LAB /  mast
cells showed an increased elevation of intracellular calcium
after stimulation compared with WT cells, suggesting that
LAB might negatively regulate calcium mobilization. Inter-
estingly, 2KO mast cells, in which both genes were deleted,
mobilized very minimal calcium upon stimulation.
Activation via the Fc RI also leads to activation of
MAPKs. To examine MAPK activation in WT, LAT / ,
LAB / , and 2KO mast cells, samples from Fig. 4 A were
also analyzed by blotting with antibodies against active Erk,
Jnk, and p38. Equal amounts of proteins loaded on each
lane were indicated by an anti-Lyn blot. Disruption of the
Lab gene in mast cells had no obvious effect on activation of
p38 and Jnk; however, Erk activation in LAB /  cells was
significantly increased in comparison with Erk activation in
WT, LAT / , and 2KO mast cells (Fig. 5 B). In contrast,
LAT /  mast cells failed to activate JNK and p38; however,
Erk activation appeared to be normal in LAT /  mast cells.
Similar to LAT /  mast cells, 2KO mast cells had no p38
and Jnk activation, but Erk activation in 2KO cells was re-
duced compared with activation in LAT /  cells.
Fc RI-mediated Cytokine Production. Engagement of the
Fc RI receptor also leads to production of multiple cyto-
kines. To analyze the effect of LAB on cytokine produc-
tion, mast cells were sensitized with anti-DNP IgE and
cross-linked with DNP-HSA for 1 h. Total RNAs were
then prepared from resting or stimulated WT, LAT / ,
LAB / , and 2KO cells. Cytokine RNA levels for IL-3, IL-4,
IL-6, and TNF  were determined by RT-PCR. Ampli-
fication of the actin transcript indicated that similar amounts
of cDNAs were used in each reaction (not depicted). As
Figure 4. Phosphorylation of signaling
proteins downstream of Fc RI engagement.
BMMCs were sensitized with anti-DNP
IgE and then stimulated with DNP-HSA
for the indicated time. (A) Protein phos-
phorylation in whole cell lysates was detected
by antiphosphotyrosine (pTyr). LAT and
LAB proteins were detected by anti-LAT
and LAB, respectively. (B) Phosphorylation
of PLC- 1, PLC- 2, and SLP-76 in WT,
LAT / , LAB / , and 2KO BMMCs. Ly-
sates were immunoprecipitated with anti–
PLC- 1, PLC- 2, and SLP-76 antibodies.
Phosphorylation of PLC- 1, PLC- 2, and
SLP-76 was detected by Western blotting
with anti-pTyr. Similar amounts of proteins
were immunoprecipitated as indicated by
blotting with anti–PLC- 1, PLC- 2, or
SLP-76 antibodies.
Figure 5. MAPK activation and Ca2  flux in BMMCs from WT,
LAT / , LAB / , and 2KO after Fc RI engagement. (A) Ca2  mobili-
zation. BMMCs were sensitized with anti-DNP IgE and then loaded
with Fluo-4 AM. DNP-HSA was used to induce Ca2  mobilization.
(B) Activation of Erk, p38, and Jnk in BMMCs. Whole cell lysates were
blotted with antibodies against the activated forms of Erk, p38, and Jnk.
Similar amounts of lysates were loaded on SDS-PAGE as indicated by an
anti-Lyn blot.Zhu et al. 997
shown in Fig. 6 A, after being sensitized LAB /  mast cells
already produced significant amounts of RNAs for IL-3, IL-4,
IL-6, and TNF before cross-linking. After cross-linking
with DNP-HSA, LAB /  cells produced more IL-4 and
TNF-  than WT cells but similar amounts of IL-3 and IL-6
RNAs. Compared with WT cells, production of IL-3, IL-4,
IL-6, and TNF  RNAs was dramatically reduced in LAT / 
mast cells as reported previously (19). Interestingly, produc-
tion of these RNAs was further reduced in 2KO mast cells.
We also quantitated the amounts of cytokines secreted into
the tissue culture supernatants after stimulation using multi-
plex cytokine assay. As shown in Fig. 6 B, LAB /  mast
cells produced more IL-2, IL-3, Il-4, IL-6, MIP-1 , and
TNF  after activation for 3 or 8 h than WT cells, whereas
LAT /  and 2KO cells produced very minimal amounts of
cytokines. These results suggested that LAB negatively reg-
ulates Fc RI-mediated cytokine production.
Competition of LAT and LAB for Raft Localization. Our
data showed that Fc RI-mediated signaling was enhanced
in LAB /  mast cells. To find out how LAB deficiency af-
fects Fc RI-mediated signaling, we examined whether re-
moval of either LAT or LAB by gene targeting affects raft
localization of LAB or LAT, since both are localized in
lipid rafts. We isolated lipid raft and nonraft fractions from
WT, LAT / , and LAB /  mast cells by ultracentrifuga-
tion on a sucrose gradient. Each fraction was analyzed by
Western blotting with LAB, LAT, Lyn, and PLC- 2 anti-
bodies. In WT mast cells, LAT was present in both lipid
raft (fractions 2–4) and nonraft fractions (fractions 8–12).
Interestingly, unlike LAB in B cells, most of the LAB pro-
tein was present in nonraft fractions in WT mast cells (Fig.
7). In LAT /  mast cells, most of the LAB protein was de-
tected in raft fractions. Compared with WT mast cells,
LAB /  mast cells had more LAT in lipid raft fractions and
less LAT in Triton-soluble fractions. The distribution of
Lyn and PLC- 2 was similar in WT, LAT / , and LAB / 
mast cells. These results suggested that LAT and LAB
might compete for raft localization. In the absence of LAT,
more LAB protein is targeted to lipid rafts, leading to in-
creased tyrosine phosphorylation of LAB as indicated in
Fig. 2 B. In the absence of LAB, more LAT moves into
rafts, thus enhancing Fc RI-mediated signaling.
Discussion
In our study, we used mast cells derived from LAB-defi-
cient mice to study how this adaptor molecule functions in
Figure 6. Increased cytokine
production in LAB /  mast cells.
(A) Semiquantitative RT-PCR
for determination of cytokine
RNAs. BMMCs were sensitized
with anti-DNP IgE and stimu-
lated with DNP-HSA for 1 h.
RNAs were isolated from sensi-
tized BMMCs before ( ) and
after  cross-linking with DNP-
HSA ( ). Relative levels of cyto-
kine RNAs were detected by
RT-PCR using specific primer
pairs for each cytokine. For stim-
ulated samples, cDNAs after dilu-
tion at 1:5 and 1:25 were also
used in PCR reactions. (B) Cyto-
kine production by mast cells.
Cytokines secreted into the tissue
culture supernatant by mast cells
before (0 h) and after cross-linking
for 3 or 8 h were quantitated by a
multiplex cytokine assay.
Figure 7. Localization of LAB and LAT in lipid rafts. BMMCs from
WT, LAT / , and LAB /  mice were lysed in 1% Triton before ultra-
centrifugation on a sucrose gradient. 12 fractions were collected starting
from the top of the sucrose gradient. Each fraction was resolved on SDS-
PAGE and blotted with anti-LAB, LAT, PLC- 2, and Lyn, respectively.LAB/NTAL in Mast Cell Signaling 998
Fc RI-mediated signaling and effector function. Our data
suggested that LAB negatively regulates Fc RI-mediated
signaling. We also compared Fc RI-mediated signaling in
mast cells derived from the WT, LAT / , LAB / , and
2KO mice. Our data indicated that, although LAT plays a
dominant role, LAB also has a positive role in Fc RI-
mediated signaling and effector function.
Disruption of Lat, Lab, or both did not affect IL-3–
dependent mast cell growth, suggesting that these two
molecules are not required in IL-3 receptor–mediated sig-
naling. In LAB /  mast cells, Fc RI-mediated tyrosine phos-
phorylation of cellular proteins was relatively normal com-
pared with that in WT cells, indicating that proximal PTK
activation was not affected by deficiency of LAB. However,
phosphorylation of PLC- 1 and PLC- 2 was increased.
Increased tyrosine phosphorylation of PLC- 1 and PLC-
 2 normally correlates with an increase in its enzymatic ac-
tivity, leading to increase in inositol 1,4,5-trisphosphate
and diacylglycerol (DAG) production. Indeed, when we
measured Fc RI-mediated calcium flux we observed a
significant increase in LAB /  cells, likely caused by in-
creased inositol 1,4,5-trisphosphate production. In addi-
tion, Fc RI-mediated Erk activation was increased, a con-
sequence of PKC or Ras-GRP activation by increased
production of DAG. Enhanced calcium flux and Erk acti-
vation further led to an increase in mast cell effector func-
tion, such as degranulation and cytokine production. These
data suggested that, different from LAT, LAB functions as a
negative regulator in Fc RI-mediated signaling. These re-
sults were apparently different from those obtained using
siRNA to knock down LAB protein (23). Reduced LAB
expression was found to abolish Fc RI-mediated signaling
and mast cell function. The reason for this discrepancy is
not clear. One possibility is that LAB siRNA might also af-
fect expression of other protein(s) involved in Fc RI-
mediated signaling.
Previous studies showed that Fc RI-mediated signaling
is not completely blocked in LAT /  mast cells. LAT / 
cells still flux calcium and produce cytokines, although at
reduced levels. Thus, the impact of LAT deficiency is less
severe on Fc RI-mediated signaling compared with its ef-
fect on TCR-mediated signaling. In LAT-deficient Jurkat
cells, TCR-mediated calcium flux and MAPK activation
are completely blocked. This suggests that coupling of cal-
cium flux and MAPK activation to Fc RI engagement is
not solely dependent on LAT. Our data indicated that LAB
might play a similar role as LAT. When both LAT and
LAB were deficient in mast cells, Fc RI-mediated calcium
flux was completely absent and Erk activation was further
reduced compared with Erk activation in LAT /  mast
cells. In the LAT /  cells, Fc RI-mediated IL-3, IL-6, and
TNF production was reduced. Cytokine production in
2KO mast cells was further reduced as detected by RT-
PCR. These data suggested that LAB also functions posi-
tively in Fc RI-mediated signaling by coupling Fc RI en-
gagement to MAPK activation and calcium flux.
LAT and LAB share similar structural motifs. Although
both adaptor proteins are capable of binding Grb2, LAB is
unable to bind PLC- 1. When the Lab gene was used to
reconstitute LAT-deficient Jurkat cells, it could partially
rescue Ca2  flux (26) or MAPK activation (21). Transgenic
mice that express LAB in T cells under the CD2 promoter
have a similar autoimmune phenotype as the LAT Y136F
knockin mice (24, 27, 28). These mice have splenomegaly
and massive lymphocyte infiltration. T cells in these mice
are hyperactivated and produce large amounts of Th2 cyto-
kines. Therefore, LAB functions like the LAT mutant
without the PLC- 1 site. In LAT /  mast cells, more LAB
was phosphorylated. Although LAB does not bind PLC- 1
or PLC- 2 directly, perhaps LAB could recruit PLC- 1 or
PLC- 2 to the membrane through binding of the Gads–
SLP76–PLC-  complex. Since recruitment through LAB
might be not as efficient as through LAT, Fc RI-mediated
calcium flux is thus compromised in LAT /  cells. When
both molecules are absent as in 2KO cells, there is no re-
cruitment PLC- 1 or PLC- 2 to the membrane, resulting
in a complete block in Fc RI-mediated calcium flux.
It is surprising that disruption of the Lab gene enhanced
Fc RI-mediated signal transduction. Since LAB and LAT
have similar structures, we expected to see reduced Fc RI-
mediated signaling when the Lab gene was deleted. The rea-
son for this enhanced mast cell function is not entirely clear.
One possibility is that LAB and LAT might compete for
binding of Grb2. Without LAB, LAT could bind more
Grb2 and their associated proteins, thus enhancing Fc RI-
mediated MAPK activation and calcium flux. A more likely
possibility, as suggested in Fig. 7, is that LAT and LAB com-
pete for localization to lipid rafts. In WT mast cells, LAT is
the dominant one. It keeps most of the LAB protein away
from lipid rafts. In the absence of LAT, more LAB moves
into lipid rafts, leading to more tyrosine phosphorylation of
LAB and further compensation for loss of LAT. This is
probably the reason why LAT deficiency only causes a par-
tial block in Fc RI-mediated signaling. In the absence of
LAB, more LAT moves into lipid rafts and binds more sig-
naling proteins, thus enhancing Fc RI-mediated phosphor-
ylation of PLC- 1 or PLC- 2, MAPK activation, calcium
flux, degranulation, and cytokine production. Therefore,
LAB might negatively regulate Fc RI-mediated signaling by
competing with LAT to localize to lipid rafts. However,
whether lipid rafts exist and function still remains controver-
sial (29). Our data in Fig. 7 might simply indicate changes of
LAT or LAB in its physical properties, such as palmitoyla-
tion, or subcellular localization when the other one is absent.
How and at what levels LAB competes with LAT to localize
to rafts remain to be investigated in the future.
Although we observed enhanced Fc RI-mediated sig-
naling in mast cells derived from BM cells of LAB /  mice,
we did not see a significant enhancement of anaphylaxis in
vivo. It is possible that there is a compensatory mechanism
in vivo to control hyperactive mast cells. Interestingly, the
basal IgE level in naïve LAB /  mice is higher than the
basal IgE level in WT mice (unpublished data). Mast cells
in LAB /  mice might bind less anti–DNP-IgE after sensi-
tization than cells in WT mice, since exogenous IgE has
to compete with endogenous IgE to bind Fc RI. EvenZhu et al. 999
though Fc RI-mediated signaling is enhanced in LAB / 
mast cells, engagement of the Fc RI in LAB /  mice
might not be as efficient as it in WT mice. It is also possible
that cross-linking with DNP-HSA, which induces anaphy-
laxis in sensitized mice, already causes a very strong stimu-
lation in WT mice; therefore, it might be difficult to ob-
serve enhanced mast cell function using this assay. In
addition, because there are some variations in the anaphy-
laxis assay even among different mice with the same ge-
netic background, it is difficult to detect enhanced mast
cell-mediated anaphylaxis even if it does occur in vivo.
Compared with the effect of LAT deficiency on T cell
development, disruption of Lab did not have a significant
impact on B cell development as normal populations of
pro–, pre–, and mature B cells are present in LAB-deficient
mice. Therefore, even though LAB can substitute LAT in
T cell development and partially rescues calcium flux in
LAT-deficient cells, LAB does not function like LAT in B
cells. It is possible that in B cells BCR-mediated signaling
does not use a LAT-like molecule to signal. In T cells, re-
cruitment of SLP-76 and PLC- 1 to the membrane and
further activation of Ras-MAPK and calcium flux depend
on LAT; however, in B cells SLP-65/BLNK can be re-
cruited to the BCR by interacting directly with the Ig 
chain (30, 31). BLNK then recruits PLC- 1/ 2 to the
membrane by interacting with them directly. It is also pos-
sible that other membrane-associated molecules might exist
to function like LAT in B cells. Although LAB deficiency
had no effect on B cell development, we could not exclude
the possibility that B cell function is affected by disruption
of Lab. We are currently investigating whether BCR-
mediated signaling, B cell function, and immune responses
are normal in these mice.
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